FDA Approves AstraZeneca's Ovarian Cancer Treatment Lynparza Tablets
August 18 2017 - 2:49AM
Dow Jones News
By Rory Gallivan
LONDON--AstraZeneca PLC (AZN.LN) and Merck & Co. Inc. (MRK)
on Friday said the U.S. Food and Drug Administration has approved a
new tablet form of the ovarian cancer treatment Lynparza.
The two drug companies are collaborating on developing and
marketing Lynparza, which was initially developed by
AstraZeneca.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter:
@RoryGallivan
(END) Dow Jones Newswires
August 18, 2017 02:34 ET (06:34 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024